Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA

Simple item page
dc.contributor.authorRubín de Célix, Cristina
dc.contributor.authorRicart, Elena
dc.contributor.authorMartín Arranz, María Dolores
dc.contributor.authorFrancisco, Ruth de
dc.contributor.authorGarcía Alonso, Francisco Javier
dc.contributor.authorMesonero, Francisco
dc.contributor.authorGomollón, Fernando
dc.contributor.authorCastro, Luisa de
dc.contributor.authorRamos, Laura
dc.contributor.authorPajares, Ramón
dc.contributor.authoret al.
dc.date.accessioned2026-06-23T13:06:08Z
dc.date.available2026-06-23T13:06:08Z
dc.date.issued2025
dc.description.abstractReal-world data on dose escalation/de-escalation in inflammatory bowel disease (IBD) are scarce. In the long term, some patients with IBD need biologic escalation, which frequently recaptures durable clinical remission. De-escalation is feasible in some patients. Re-escalation is generally effective after relapse.en
dc.description.filiationUEMspa
dc.description.impact6.8 Q1 JCR 2025
dc.description.impact3.006 Q1 SJR 2025
dc.description.impactNo data IDR 2024
dc.description.sponsorshipEli Lilly and Company apoyó el análisis estadístico, la redacción médica y los costes de publicación, sin implicación en el diseño, análisis o interpretación del estudio.es
dc.description.sponsorshipVer financiación en https://doi.org/10.1111/apt.70312es
dc.identifier.citationRubín De Célix, C., Ricart, E., Martín‐Arranz, M. D., De Francisco, R., García‐Alonso, F. J., Mesonero, F., Gomollón, F., De Castro, L., Ramos, L., García‐López, S., Arias, L., Mañosa, M., Iglesias, E., Calvet, X., Suria Bolufer, C., Casanova, M. J., Pérez‐Calle, J. L., Giordano, A., Sierra‐Ausín, M., … Gisbert, J. P. (2026). Frequency and Effectiveness of Dose Escalation and De‐Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW ‐ IBD Study of ENEIDA. Alimentary Pharmacology & Therapeutics, 63(1), 93-108. https://doi.org/10.1111/apt.70312
dc.identifier.doi10.1111/apt.70312
dc.identifier.issn0269-2813
dc.identifier.urihttps://hdl.handle.net/11268/17176
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttps://doi.org/10.1111/apt.70312
dc.rights.accessRightsembargoed access
dc.subject.otherEnfermedades Autoinmunes
dc.subject.otherEnfermedades Inflamatorias del Intestino
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoCiencias médicas
dc.subject.unescoInmunología
dc.subject.unescoFarmacología
dc.titleFrequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDAen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Frequency_Effectiveness_Dose.pdf
Size:
21.79 KB
Format:
Adobe Portable Document Format
Download

Collections

Área de Ciencias de la Salud